Reduction-responsive supramolecular hybridized paclitaxel nanoparticles for tumor treatment

Powerful chemotherapeutics have been used to combat tumor cells, but serious adverse effects and poor therapeutic efficiency restrict their clinical performance. Herein, we developed reduction-responsive supramolecular hybridized paclitaxel nanoparticles (PTX@HOMNs) for improved tumor treatment. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuhan, Cui, Yingli, Dai, Tinggeng, Yue, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505395/
https://www.ncbi.nlm.nih.gov/pubmed/37724094
http://dx.doi.org/10.3389/fbioe.2023.1257788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505395/
https://www.ncbi.nlm.nih.gov/pubmed/37724094
http://dx.doi.org/10.3389/fbioe.2023.1257788

Ejemplares similares